Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study

Objective To compare differences in mortality between women concomitantly treated with tamoxifen and selective serotonin reuptake inhibitors (SSRIs) that are potent inhibitors of the cytochrome-P450 2D6 enzyme (CYP2D6) versus tamoxifen and other SSRIs. Design Population based cohort study. Setting F...

Descripción completa

Detalles Bibliográficos
Autores principales: Donneyong, Macarius M, Bykov, Katsiaryna, Bosco-Levy, Pauline, Dong, Yaa-Hui, Levin, Raisa, Gagne, Joshua J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044871/
https://www.ncbi.nlm.nih.gov/pubmed/27694571
http://dx.doi.org/10.1136/bmj.i5014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044871/
https://www.ncbi.nlm.nih.gov/pubmed/27694571
http://dx.doi.org/10.1136/bmj.i5014

Ejemplares similares